PharmTech Drug Digest 11.20
News|Articles|August 27, 2018

Leistritz Expands NJ Laboratory

The company installed a ZSE-3D twin screw extrusion system at its Somerville, NJ process laboratory.

On Aug. 27, 2018, Leistritz announced the installation of a ZSE-3D twin-screw extrusion system at its Somerville, NJ process laboratory. The system facilitates the development and production of 3D filaments from a co-rotating or counter-rotating twin screw extruder.

According to the company, direct extrusion of raw materials enables rapid product sampling and also results in one-less heat and shear history as compared to two-step processes, which is beneficial for heat and shear sensitive formulations.

The system features the following: 

  • Configuration for continuous mixing of polymers, actives, and excipients

  • Loss-in-weight feeders for pellets, powders, or fibers

  • Liquid injection system

  • Gear pump front-end attachment

  • 3D filament die for 1–5 mm diameter parts

  • Air-rack or water tank with sizing bushing

  • Downstream system consisting of a belt puller, laser gauge, and winder (or cutter).

The company states that the system is suitable for in-line compounding of excipients with APIs, to quickly develop new filaments and formulations. Formulations can be modified extemporaneously for rapid sampling of filaments with different formulation percentages. A sample can be produced every 10 minutes. The filament system is configured for water-soluble and high-temperature applications.

Source: Leistritz


Related to this article

Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.